Case of a Girl with Special Needs Seeking Menstrual Management


Category

Method

Brand names

Mechanism

Frequency of use

Menstrual suppression

Considerations in the special needs population

Estrogen- and progesterone-containing methods

Combined oral contraceptive

Many options available, ranging from first- to fourth-generation COCs

Inhibit ovulation via a negative feedback mechanism on the hypothalamus. Changes in the endometrium occur, reducing the amount of bleeding

Daily dosing

Can space menses out with extended (withdrawal bleed every 3 months) or continuous (no withdrawal bleed) regimens but may have breakthrough bleeding

• Possible drug-drug interactions with antiepileptic agents

• Possible increased risk of VTE with limited mobility

Ring

NuvaRing

Inhibit ovulation via a negative feedback mechanism on the hypothalamus. Changes in the endometrium occur, reducing the amount of bleeding

Monthly

Can space menses out with extended (withdrawal bleed every 3 months) or continuous (no withdrawal bleed) regimens but may have breakthrough bleeding

• Possible drug-drug interactions with antiepileptic agents

• Possible increased risk of VTE with limited mobility may require assistance with insertion

Patch

Ortho Evra, Xulane

Inhibit ovulation via negative feedback on the hypothalamus. Changes in the endometrium occur, reducing the amount of bleeding

Weekly

Can space menses out with extended or continuous cycling, but clot risk may be increased and breakthrough bleeding may occur

• Possible drug-drug interactions with antiepileptic agents

• Possible increased risk of VTE with limited mobility

• Patients may inadvertently remove patch

Progesterone-only methods

Progesterone-only pill

Micronor, Nor-QD

Negative feedback on the hypothalamus prevents follicular maturation and ovulation and causes endometrial thinning

Daily

May cause irregular bleeding with lighter, delayed, or absent periods. Amenorrhea can occur. Breakthrough bleeding is common

• Possible drug-drug interactions with antiepileptic agents

• Irregular bleeding/breakthrough bleeding

Depot medroxyprogesterone acetate

Depo-Provera, Depo-SubQ Provera 104, Provera

Negative feedback on the hypothalamus prevents follicular maturation and ovulation and causes endometrial thinning

10–12 weeks

Irregular bleeding initially, high rates of amenorrhea after long-term use (52–64% at 1 year, 71% at 2 year)

• Irregular/breakthrough bleeding

• Bone density

• Potential for weight gain

Implant

Nexplanon

Negative feedback on the hypothalamus prevents follicular maturation and ovulation and causes endometrial thinning

3 years

Irregular

• Irregular bleeding

• Insertion may be anxiety-provoking/painful

Intrauterine device

Mirena, Skyla

Negative feedback on the hypothalamus leads to thickening of the cervical mucus, alteration of the endometrium preventing implantation, and inhibition of ovulation

Mirena – 5 years

Skyla – 3 years

Initial irregular bleeding, but after 6 months most women experience lighter, infrequent, or absent periods. Up to 50% of patients have amenorrhea at 1 year after insertion

• Irregular bleeding in the initial 6 months after insertion

• May need anesthesia for insertion and removal

• Patients may be unable to check strings

Surgical

Endometrial ablation
 
Selectively destroys the endometrial lining to prevent heavy bleeding

Single procedure

Amenorrhea rates are low in an adolescent population

• Ethical and legal considerations

• Long-term data needed

Hysterectomy
 
Removal of uterus prevents pregnancy and menstrual bleeding

Permanent

Permanent amenorrhea

• Ethical and legal considerations

• Not recommended by AAP or ACOG for menstrual suppression unless medically indicated for other reasons

• Permanent sterilization

Miscellaneous

Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen

Aspirin, Advil, Motrin, Voltaren, etc.

Reduces prostaglandin (PGE2 and PGF2 alpha) synthesis in the endometrium, leading to vasoconstriction and reduced bleeding

Frequency depends on medication. Start treatment on the first day of menses and continue for 4–5 days or until menstruation ceases

May improve dysmenorrhea and decrease ovulatory menstrual bleeding by 30–40%

• Nonhormonal does not provide pregnancy prevention

• No increase in clotting risk in adolescents






Special Considerations



Clot Risk in Adolescents with Limited Mobility


Several studies have sought to determine whether individuals with limited mobility have an increased risk of venous thromboembolism. One study of adult patients with multiple sclerosis found a high rate of deep venous thrombosis (43.9%) of patients, with 24.2% of patients having a history of venous thromboembolism [38]. However, in a sample of para- and tetraparesic patients institutionalized for long durations, no thromboembolisms were observed despite additional risk factors including orthopedic surgery, bone fractures, and hormonal therapy in 60% of participants [39]. Researchers have hypothesized that quadriplegia during childhood may reduce venous lakes, decreasing blood stasis and allowing for a closer to normal risk of venous thromboembolism when compared to patients who acquire quadriplegia later in life [40]. In addition, spasticity may play a role in preventing DVT in patients with limited mobility [39]. No studies to date have examined the risk of venous thromboembolism among adolescents with limited mobility on hormonal contraception. Thus, the risks and benefits of available methods should be discussed with families prior to initiating a hormonal method of contraception, and a thorough history for patient and familial risk factors should be conducted. If patients and families opt to proceed with combined oral contraceptives, first- and second-generation COCs are optimal given their better clotting profile compared to third- and fourth-generation progestin-containing contraceptives. Further data is necessary to identify whether adolescents with limited mobility are at increased risk of venous thromboembolism when taking hormonal contraceptives .


Sexual Abuse


Adolescents with disabilities are often not viewed as targets for sexual abuse by their family and other members of their community. However, because their intellectual limitations may prevent them from identifying an advance as inappropriate or disclosing the abuse to a caregiver or other adult, some perpetrators may view adolescents with disabilities as an easy target [41]. One study demonstrated that women with severe disability impairments were four times more likely to be sexually assaulted than women with no reported disabilities. Children with disabilities often have limited access to critical information pertaining to personal safety and sexual abuse prevention, and parents of children with disabilities may object to a sexual education curriculum on human sexuality for their adolescents [42]. Pediatricians and pediatric and adolescent gynecologists can help to educate parents about normal sexual development and encourage them to advocate for their children to have appropriate sexual education in the school setting [43]. In the school setting, individualized educational plans (IEPs) can be set up to include human sexuality education geared at an appropriate intellectual level [44]. For example, educational activities can involve parents, teachers, and other care providers and may include role-play, visual aids, and frequent repetition of simple concepts and tasks.

At the University of Michigan, Dr. Elizabeth Quint and colleagues have developed counseling strategies to help prevent abuse. The circle of life helps explain relationships to youth with developmental disabilities. The inner circle involves parents and those closest to the child with the developmental disability, with the explanation that those family members would be appropriate to kiss or hug. The next circle might involve extended family, who it might be appropriate to hug. Next would be peers, teachers, and others in daily life, who it might be appropriate to say hello and give a handshake. Acquaintances might get a wave, while strangers might just be observed but not touched or engaged in conversation. Another example per Dr. Quint and colleagues is the No-Go-Tell strategy , where children with developmental disabilities—and all younger children—are taught their own first line of defense: “say No” to unwanted or unexpected contact, tell the person to “Go away”, and then “Tell” someone, no matter what they are told by the perpetrator. This No-Go-Tell strategy can help prevent a cycle of abuse with a developmentally challenged child or adolescent.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 26, 2018 | Posted by in GYNECOLOGY | Comments Off on Case of a Girl with Special Needs Seeking Menstrual Management

Full access? Get Clinical Tree

Get Clinical Tree app for offline access